Major adverse limb events

1 paper1 finding

Animals1

Associations

1

STAT3

downin humans1

1 study

STAT3 is associated with major adverse limb events in humans.
“in patients with limb ischemia we also observed a higher expression of circulating STAT3, associated with a lower rate of major adverse limb events (MALEs)”
Humansin patients with limb ischemia
Effects of STAT3 on aging-dependent neovascularization impairment following limb ischemia: from bedside to bench
AgingJun 13, 2022

Latest

10 in 12 months

medRxivOct 8

Blood enzyme and frailty score help predict vascular surgery risks

An observational study of 657 patients found that combining the two measures improved risk prediction beyond standard clinical factors.An observational study of 657 patients found that combining the two measures improved risk prediction beyond standard clinical factors.

Preprint: cohort study of 657 peopleBiomarkers

British Journal of Hospital MedicineSep 30

GLP-1 Receptor Agonists in Diabetic Lower Extremity Peripheral Artery Disease: From Mechanisms to Clinical Practice

ReviewGLP-1 receptor agonists

Diabetes & MetabolismSep 26

Clinical outcomes associated with glucagon-like peptide-1 receptor agonist therapy in patients with peripheral artery disease and diabetes

Cohort study of 20,031 peoplePeripheral artery disease

Annals of Vascular SurgerySep 8

Prognostic Value of Frailty in Chronic Limb-Threatening Ischemia (CLTI) Revascularization: A Systematic Review and Meta-Analysis

Meta-analysis of observational studiesFrailty

CirculationAug 18

Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial

Randomized trial in 13,970 peopleBempedoic acid

Cardiovascular Intervention and TherapeuticsAug 18

Association of pre-procedural activities of daily living status with all-cause mortality after femoropopliteal endovascular therapy

Cohort study of 418 peoplePopulations

International Journal of Cardiology Cardiovascular Risk and PreventionAug 11

Risk stacking in peripheral artery disease (PAD): Integrating genetics, cardiometabolic disease and social determinants of health to explain worsening PAD outcomes

ReviewPeripheral artery disease

ADA Scientific Sessions 2026 AbstractJun 8

Major Adverse Limb Events with Tirzepatide vs. Injectable Semaglutide in Adults with Type 2 Diabetes and Peripheral Artery Disease

Cohort study of 24,274 peopleTirzepatide

AHA Scientific Sessions 2025 AbstractNov 3

Glucagon-like-peptide-1 Receptor Agonists Are Associated with Lower Postoperative Complication Rates in Patients with Peripheral Artery Disease

Cohort study of 5,008 peoplePeripheral artery disease

AHA Scientific Sessions 2025 AbstractNov 3

Real-World Outcomes of Tirzepatide Versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes and Peripheral Arterial Disease

Cohort study in peopleGLP-1 receptor agonists